|
|
|
Insider
Information: |
Steinmetz Michael |
Relationship: |
Former 10% stockholder |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
37,029,187 |
|
Indirect Shares
|
18,165,939 |
|
|
Direct
Value |
$300,418,977 |
|
|
Indirect Value
|
$337,643,891 |
|
|
Total
Shares |
55,195,126 |
|
|
Total
Value |
$638,062,868 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Oscient Pharmaceuticals Corp |
OSCIQ |
10% Owner |
2004-02-06 |
7,597,351 |
2009-05-15 |
4,222 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-08-02 |
0 |
2004-08-02 |
1,833,597 |
Premium* |
|
Acorda Therapeutics Inc |
ACOR |
Director |
2006-02-15 |
0 |
2006-02-15 |
1,806,800 |
Premium* |
|
Avanir Pharmaceuticals |
AVNR |
10% Owner |
2008-04-04 |
15,557,318 |
2010-12-03 |
12 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2008-08-13 |
5,163,689 |
2012-06-04 |
3 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
5,982,439 |
2011-09-16 |
9,482,439 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2013-09-30 |
2,728,390 |
2013-09-30 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
Director, 10% Owner |
|
0 |
2013-11-21 |
2,579,062 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2012-06-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,942,468) |
3 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,669,204) |
12 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-08-20 |
4 |
B |
$2.49 |
$12,140,000 |
I/I |
4,875,502 |
9,262,079 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,232,439 |
4,232,439 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
9,482,439 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2012-05-31 |
4 |
OE |
$3.11 |
$9,868,206 |
I/I |
2,997,348 |
12,259,427 |
0 |
- |
|
ISEE |
Iveric Bio Inc |
10% Owner |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,728,400 |
2,728,390 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-01 |
4 |
S |
$5.36 |
$13,273,424 |
I/I |
(2,478,142) |
10,937,391 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$7,000,000 |
D/D |
1,750,000 |
5,982,439 |
2.45 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2006-02-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,640,133 |
1,640,133 |
|
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-10-29 |
4 |
S |
$5.06 |
$7,215,647 |
I/I |
(1,424,947) |
13,415,533 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-03 |
4 |
S |
$4.52 |
$6,332,539 |
I/I |
(1,400,106) |
8,246,414 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2012-05-31 |
4 |
S |
$7.49 |
$9,868,215 |
I/I |
(1,316,956) |
10,942,471 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-02 |
4 |
S |
$4.49 |
$5,800,400 |
I/I |
(1,290,871) |
9,646,520 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Former 10% stockholder |
|
2016-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,229,902) |
2,459,804 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-09 |
4 |
S |
$4.81 |
$5,773,920 |
I/I |
(1,200,000) |
6,669,216 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-05 |
4 |
S |
$4.80 |
$1,597,377 |
I/I |
(332,572) |
7,913,842 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-10-11 |
4 |
S |
$3.52 |
$1,093,445 |
I/I |
(311,000) |
14,840,480 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-23 |
4 |
AS |
$3.70 |
$981,428 |
I/I |
(264,900) |
4,677,167 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-10-08 |
4 |
S |
$3.47 |
$836,792 |
I/I |
(240,838) |
15,151,480 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-01-11 |
4 |
AS |
$3.77 |
$881,370 |
I/I |
(233,990) |
4,386,577 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2006-02-15 |
4 |
B |
$6.00 |
$1,000,002 |
I/I |
166,667 |
1,806,800 |
2.1 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-07-13 |
4 |
S |
$3.53 |
$583,143 |
I/I |
(165,000) |
15,392,318 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-17 |
4 |
AS |
$3.50 |
$453,166 |
I/I |
(129,476) |
4,971,067 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-16 |
4 |
AS |
$3.58 |
$242,507 |
I/I |
(67,800) |
5,100,543 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|